2-bromopalmitate has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GQ; Gao, MQ; Lu, Y; Qin, K; Qu, XN; Sun, YT; Xia, L; Xu, HT; Yan, JS; Yin, QQ | 1 |
1 other study(ies) available for 2-bromopalmitate and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia.
Topics: Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Palmitates; Retinoic Acid Receptor alpha; Tretinoin; Xenograft Model Antitumor Assays | 2019 |